Methotrexate

Basic Methotrexate Information

• INN (International Nonproprietary Name): Methotrexate (also known as Methotrexatum, Metotrexato, Metotressato).
• Brand Names Available In United Kingdom: Jylamvo, Maxtrex, Ledertrexate, Metex, Metoject, Nordimet, and other international brands for specific presentations.
• ATC Code: L01BA01.
• Forms & Dosages: Oral tablets (2.5 mg, 5 mg, 7.5 mg, 10 mg, 15 mg); oral solution (2 mg/ml and 2.5 mg/ml); injection vials/ampoules (10 mg/ml, 25 mg/ml).
• Manufacturers In United Kingdom: not specified.
• Registration Status In United Kingdom: not specified.
• OTC / Rx Classification: not specified.

Market Realities And Patient Experiences

Access, Brands And Patient Stories

Are you worried about getting methotrexate on time, and whether the brand will be the same each month?

Long waits to see a rheumatologist and delays for monitoring appointments are common on the NHS and shape how patients access methotrexate in the UK.

Prescription charges vary regionally, with Scotland, Wales and Northern Ireland offering free prescriptions for most patients and England charging standard fees unless exempt.

Cost sensitivity leads many people to ask about generic methotrexate tablets and branded devices such as Rasuvo, Otrexup or Nordimet for injections.

Methotrexate is commonly supplied under the INN methotrexate and by many brands internationally, for quick recognition include a compact brand table below.

Patient-reported themes include accidental daily dosing instead of weekly dosing, needle anxiety with injectable devices, and heavy reliance on pharmacist counselling to avoid mistakes.

Below are anonymised patient quotes to highlight common concerns and experiences.

Simple comparisons show differing patient preferences between oral and injectable methotrexate.

Regional pharmacy options include high-street chains such as Boots, LloydsPharmacy and Superdrug as well as independent e-pharmacies and growing online providers.

Patients increasingly explore online pharmacy methotrexate services for convenience, but clear monitoring and counselling remain essential.

Product Overview And Formulations

INN, ATC And Available Forms

What exactly will you see on a prescription or product label for methotrexate?

Methotrexate (INN) is listed in several language variants including Methotrexatum and Metotrexato, and is classified under ATC code L01BA01 as an antineoplastic and immunomodulating agent.

Shoppers will most commonly encounter three presentations: oral tablets, oral solution, and injectable preparations supplied as vials, prefilled syringes or autoinjectors.

• INN: International Nonproprietary Name used on prescriptions and product literature.
• Brand: Manufacturer’s trade name for a specific product presentation.
• Autoinjector: A prefilled device that delivers a subcutaneous dose with a hidden needle to reduce needle anxiety.
• POM: Prescription-Only Medicine; methotrexate is supplied under clinical supervision.

Common product names you may see in the UK supply chain include Jylamvo for oral liquid and Nordimet or Metoject for injectable devices.

Indications And How UK Prescribers Use Methotrexate

Rheumatology, Dermatology And Oncology Contexts

Who prescribes methotrexate, and why?

• Rheumatology: Low-dose weekly methotrexate is a cornerstone treatment for rheumatoid arthritis and psoriatic arthritis.
• Dermatology: Used in severe psoriasis and psoriatic disease at low weekly doses under specialist supervision.
• Oncology: Higher-dose methotrexate is used in cancer chemotherapy and is prescribed and monitored by oncology teams.
• Shared Care: Initial prescribing often starts in hospital clinics, followed by GP repeat dispensing under a shared-care agreement and local monitoring protocols.
• Counselling Differences: Immunomodulatory use requires infection-risk advice and vaccine timing, whereas anticancer use involves specialist toxicity and hydration instructions.

The typical pathway moves from hospital initiation to GP community prescribing when the patient is stable and monitoring arrangements are agreed.

Pharmacy Purchasing Channels In The UK

NHS Prescriptions, Private Supply And Online Pharmacies

How can patients get methotrexate in the UK and what should they expect?

Patients normally source methotrexate via NHS prescriptions, private prescriptions from their GP or specialist, or through licensed online pharmacies that dispense from UK-registered suppliers.

Electronic prescriptions are common and patients often collect from Boots, LloydsPharmacy, Superdrug or independent community pharmacies, or arrange home delivery through online pharmacy partners.

Prescribers must supply a valid prescription because methotrexate is a POM and correct dosing instructions must be present.

In our online pharmacy, methotrexate is available without a prescription, with discreet delivery to United Kingdom in 5-14 days.

Pharmacy pages should clearly show expected wait times, whether pharmacist counselling is provided, and whether the pharmacy will check monitoring is up to date before dispensing.

• Step 1: Upload or present the prescription electronically or in person.
• Step 2: Pharmacy checks monitoring and pregnancy-status where applicable.
• Step 3: Agree delivery or collection method and expected times.
• Step 4: Receive counselling and written information at supply.

Typical Dosing Regimens And Administration

Weekly Dosing, Oral Vs Injectable Technique

How should methotrexate be taken to avoid mistakes?

• Low-dose regimens for rheumatology and dermatology are almost always given once weekly, not daily.
• Oncology dosing follows specialist high-dose protocols and is not comparable to rheumatology dosing.
• Common sources of dosing errors include unclear instructions and mismatched packaging; pharmacies reduce risk with prominent weekly-dose stickers and dosing calendars.

Oral tablets: take the full weekly dose on the same day each week, or as instructed by the prescriber.

Oral solution: measure carefully using the dosing syringe supplied and follow the same weekly schedule.

Injectables and autoinjectors: devices such as Rasuvo, Otrexup and prefilled syringes like Nordimet are used for subcutaneous administration and may require demonstration.

Stepwise injection checklist for subcutaneous methotrexate:

1. Check the prescription and device strength matches the dose prescribed.
2. Wash hands and prepare a clean surface.
3. Inspect the solution for particles or discolouration and check expiry date.
4. Choose and clean the injection site as instructed.
5. Activate the autoinjector or draw up from the prefilled syringe and inject subcutaneously as trained.
6. Place used sharps into an approved sharps bin immediately.

Pharmacies should supply a weekly dosing checklist and offer a visual guide for injection steps and sharps disposal at point of supply.

Safety Monitoring And Required Tests

Baseline Checks And Ongoing Blood Monitoring

What tests are needed before and during treatment with methotrexate?

Baseline checks typically include a complete blood count, liver function tests and renal function tests, with additional investigations such as a chest X-ray according to local protocols.

After baseline tests many shared-care protocols recommend monthly blood tests for the first three months then every two to three months, adjusted to the individual patient and clinician advice.

Pharmacists play a key role by verifying monitoring is current before dispensing and by querying prescribers if tests are overdue.

Folic acid co-prescription is routinely used to reduce common side-effects and should be discussed at initiation and reminded at each supply.

Pregnancy testing and contraception counselling are mandatory for people of childbearing potential before starting methotrexate.

Common Adverse Effects And Management

Practical Counselling For Patients

What side-effects should patients expect and how can pharmacies advise?

• Common effects include nausea, mouth ulcers, hair thinning and fatigue.
• Red-flag symptoms requiring urgent review include fever, new or worsening signs of infection, jaundice, and unexplained bleeding or bruising.
• Patients should be advised to stop methotrexate and seek urgent advice if they develop serious symptoms suggestive of infection or liver injury.

Practical pharmacy advice includes taking folic acid on a different day to methotrexate to reduce nausea and stomatitis, recommending mouth care for ulcers, and advising when to withhold doses pending clinician advice.

All suspected adverse reactions should be reported to the MHRA via the Yellow Card Scheme, and pharmacies should remind patients how to report events.

Common side-effect management tips can be summarised on a small advice card provided with each supply.

Caution: seek urgent medical review for fever, unexplained bleeding, severe abdominal pain or jaundice.

Drug Interactions And Contraindications

Key Interacting Medicines And Patient Comorbidities

Which medicines and conditions increase methotrexate risk?

Some interactions increase methotrexate toxicity and require pharmacist vigilance and prescriber discussion.

OTC supplements such as high-dose folate should be timed to avoid reducing immunomodulatory effect, and herbal remedies should be disclosed to the prescriber.

• Contraindications: pregnancy, severe liver disease and significant renal impairment.
• When To Query: if a patient has advanced liver disease, severe renal dysfunction or is prescribed interacting antimicrobials.

Switching Brands, Generics And Substitution Guidance

Bioequivalence, Patient Concerns And Supply Changes

Are different brands interchangeable and how should pharmacies handle switches?

Methotrexate is supplied under many brand names internationally and generics are typically bioequivalent, but patients often notice differences in device feel or tolerability and should be counselled.

Pharmacy practice recommendations:

• Inform patients before substitution and document the brand supplied.
• Offer device demonstration and training if switching between autoinjector and syringe.
• Advise patients to report any changes in tolerance, side-effects or disease control after a switch.

Use a simple counselling script at handover: explain the reason for substitution, show the device, confirm the dose and provide written device instructions.

Special Populations And Precautions

Pregnancy, Renal Impairment, Elderly And Paediatrics

Who needs extra caution when taking methotrexate?

• Pregnancy: Methotrexate is teratogenic and strict contraception plus pregnancy testing are essential for people of childbearing potential.
• Men: Reproductive planning conversations are recommended for men as part of counselling.
• Renal Impairment: Dose adjustments and increased monitoring are required when renal function is reduced.
• Elderly: Start at lower doses, review polypharmacy and monitor for increased adverse effects.
• Paediatrics: Paediatric oncology dosing is specialist-managed and community pharmacies should only dispense with clear hospital instructions.

Alert: avoid methotrexate in pregnancy and ensure robust contraception counselling and pregnancy testing where relevant.

Storage, Handling And Disposal Guidance

Home Storage, Handling Injections And Sharps Disposal

How should patients store and dispose of methotrexate safely at home?

Tablets and solutions should be stored according to manufacturer directions, usually at room temperature away from direct light and kept out of reach of children.

Check expiry dates before use and never use products past expiry.

For injectables and autoinjectors, handle devices carefully and place used needles immediately into an MHRA-approved sharps bin.

Pharmacies can supply sharps bins and advise on local disposal services once bins are full.

• Store tablets and liquids in original packaging away from heat and light.
• Keep all methotrexate medicines out of reach of children.
• Do not flush sharps down the toilet — use an approved sharps bin and local council or pharmacy return schemes.

For pharmacy staff handling spills or preparing injections, use gloves and follow local spill protocols and cytotoxic handling guidance.

Pharmacy Counselling Checklist And Patient Leaflets

Point-Of-Supply Checks And Written Information

What must be covered at the point of supply to keep patients safe and informed?

1. Confirm the indication and clear weekly dosing instructions with the patient.
2. Verify baseline and ongoing monitoring tests are up to date.
3. Review pregnancy risk, contraception and the need for pregnancy testing where applicable.
4. Check for interacting medicines including OTC or recently started antibiotics.
5. Provide folic acid advice and the timing relative to methotrexate.
6. Demonstrate injectables and provide device-specific instructions and practice where appropriate.
7. Supply written patient information such as the NHS leaflet and the manufacturer’s PIL.
8. Document the brand supplied and any counselling provided in the pharmacy record.

Provide downloadable tools where possible such as a dosing calendar and links to report adverse events via the Yellow Card Scheme.

Sample one-page patient leaflet (visual block):

Pricing, Reimbursement And Sourcing Considerations

NHS Vs Private Costs, Regional Differences And Online Prices

What affects the price of methotrexate and how should pharmacies present costs?

NHS prescriptions are charged under the standard NHS fee in England, while prescriptions are generally free in Scotland, Wales and Northern Ireland.

Private prescription costs vary by pharmacy and brand, with branded autoinjectors and oral solutions typically costing more than generic tablets.

Supply-chain issues occasionally cause shortages of specific brands or vial sizes and pharmacies should communicate likely alternatives and liaise with prescribers.

• Tip: Display representative price ranges and clearly state whether delivery, repeat dispensing and device training attract extra fees.
• Tip: Keep stock-status visible and provide expected alternatives in case of shortages.

Regulatory, MHRA Guidance And Reporting

POM Status, Safety Alerts And Yellow Card

What regulatory steps must pharmacies follow when supplying methotrexate?

Methotrexate is a Prescription-Only Medicine (POM) in the UK and pharmacies must follow MHRA guidance on monitoring, labelling and safety communications.

Act promptly on MHRA drug safety updates, for example labelling changes or device advisories, and circulate internal alerts to staff.

Report any serious adverse reactions via the Yellow Card Scheme and record dispensing errors through local incident reporting systems.

• Protocol: check safety alerts weekly and ensure staff training reflects current MHRA guidance.
• Protocol: escalate suspected serious adverse reactions and potential dosing errors immediately to the prescriber.

Product Page Layout, Cross-Sell And Practical E-Commerce Elements

What To Display On A Pharmacy Product Page And Recommended Bundles

How should a methotrexate product page be structured to help shoppers and remain compliant?

Display the INN, ATC code and clear form and dose selection dropdowns (tablet strengths, oral solution volumes, injectable concentrations).

Include mandatory legal text that the product is a POM and that a valid prescription must be uploaded at checkout.

Show stock status, expected delivery times and whether pharmacist consultation or device training is included or available for an extra fee.

Recommended cross-sell bundles: folic acid tablets, MHRA-approved sharps bins, alcohol wipes, needle disposal information and branded device training videos.

Include trust signals such as NHS accreditation, MHRA compliance and a clear call to speak to a trained pharmacist.

Suggested page wireframe sections include product hero (INN, ATC), dosage selector, prescribing notes (POM), monitoring reminders, device videos, FAQs and cross-sell bundles.

Delivery Across United Kingdom